The Multinational Association of Supportive Care in Cancer (MASCC) shared a post on LinkedIn:
“New open access article in Supportive Care in Cancer: Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.”
Title: Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol
Authors: Janet R. Hardy, Ristan M. Greer, Anita M. Pelecanos, Georgie E. Huggett, Alison M. Kearney, Taylan H. Gurgenci, Phillip D. Good
Read the Full Article.
More posts featuring MASCC.